Cargando…
Macrophage, a potential targeted therapeutic immune cell for cardiomyopathy
Cardiomyopathy is a major cause of heart failure, leading to systolic and diastolic dysfunction and promoting adverse cardiac remodeling. Macrophages, as key immune cells of the heart, play a crucial role in inflammation and fibrosis. Moreover, exogenous and cardiac resident macrophages are function...
Autores principales: | Chen, Ganyi, Jiang, Hongwei, Yao, Yiwei, Tao, Zhonghao, Chen, Wen, Huang, Fuhua, Chen, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561843/ https://www.ncbi.nlm.nih.gov/pubmed/36247005 http://dx.doi.org/10.3389/fcell.2022.908790 |
Ejemplares similares
-
Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy
por: Zhai, Zhenyu, et al.
Publicado: (2021) -
Targeting of CAT and VCAM1 as Novel Therapeutic Targets for DMD Cardiomyopathy
por: Li, Bin, et al.
Publicado: (2021) -
Ferroptosis Related Genes in Ischemic and Idiopathic Cardiomyopathy: Screening for Potential Pharmacological Targets
por: Jiang, Yufeng, et al.
Publicado: (2022) -
Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors
por: Cassetta, Luca, et al.
Publicado: (2018) -
Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease
por: Chen, Kai, et al.
Publicado: (2021)